PROJECTS 1, 2, 3 and 4 deal with mechanisms of connective tissue morphogenesis; (1) The processes of procollagen packaging, secretion and assembly into extracellular fibrils; (2) The role and regulation of the degradative side of morphogenesis through control of collagenolysis and proteoglycan degradation in development and tumor invasion; (3) The localization of various collagen and some non collagen macromolecules in the embryonic development of the skeletal cardiovascular and ocular tissues through the use of a variety of monoclonal antibodies, immunohistologic and immunoelectron microscopy; (4) Studies on the supramolecular organization of basement membranes by a number of biophysical and biochemcal approaches. PROJECTS 5, 6, 7, and 8 outline studies designed to further explore the complex cellular and humoral interactions which are responsible for degradation of connective tissues in inflammatory diseases. Projects 5 and 6 explore the role of soluable cellular mediators and cellular interactions on release of products which have the capacity to degrade connective tissue matrices. Project 7 focuses on the structure and composition of collagens and other matrix components of connective tissue and studies factors controlling remodeling of these tissues. Project 8 investigates the biological effects and mechanisms of action of hormones which regulate connective tissues in pathological and non-pathological conditions. PROJECTS 9, 10, and 11 include a study of the biosynthesis of N-glycoproteins by use of chemically synthesized isoprenoid sugar phosphates of known structures, which will serve as acceptors for identification of the products formed, a study of glycopeptides and glycoproteins formed in diseases processes, and a study of the role of sialic acid at the surface of the cell.

Project Start
1979-03-01
Project End
1988-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
28
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Krane, Stephen M; Inada, Masaki (2008) Matrix metalloproteinases and bone. Bone 43:7-18
Krane, Stephen M (2003) Elucidation of the potential roles of matrix metalloproteinases in skeletal biology. Arthritis Res Ther 5:2-4
Riquet, F B; Tan, L; Choy, B K et al. (2001) YY1 is a positive regulator of transcription of the Col1a1 gene. J Biol Chem 276:38665-72
Riquet, F B; Lai, W F; Birkhead, J R et al. (2000) Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 6:705-19
Kokenyesi, R; Tan, L; Robbins, J R et al. (2000) Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys 383:79-90
Gravallese, E M; Manning, C; Tsay, A et al. (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-8
Zhao, W; Byrne, M H; Wang, Y et al. (2000) Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest 106:941-9
Orcel, P; Tajima, H; Murayama, Y et al. (2000) Multiple domains interacting with Gs in the porcine calcitonin receptor. Mol Endocrinol 14:170-82
Zhao, W; Byrne, M H; Boyce, B F et al. (1999) Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 103:517-24
Inoue, D; Shih, C; Galson, D L et al. (1999) Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology 140:1060-8

Showing the most recent 10 out of 60 publications